Welcome to our dedicated page for KNOREX LTD. news (Ticker: KNRX), a resource for investors and traders seeking the latest updates and insights on KNOREX LTD. stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect KNOREX LTD.'s stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of KNOREX LTD.'s position in the market.
KNOREX (NYSE American: KNRX) provided a year-end business update for 2025 highlighting commercial momentum after its September NYSE American listing. The company reported one of its strongest quarters of ad spend transacted through XPO in Q4 and filed a Form 6-K with unaudited interim results for the six months ended June 30, 2025. KNOREX said revenue declined year‑over‑year for the six months ended June 30, 2025, primarily because one customer lost a major end client, and the company shifted to diversify customers and invest incremental capital into sales and marketing. Management expects 2026 to be a year of accelerated growth as pipeline converts and customers scale.
KNOREX (NYSE: KNRX) will ring the New York Stock Exchange Closing Bell on Monday, December 29, 2025, at approximately 3:45 p.m. ET to celebrate the company’s progress and listing.
KNOREX began trading on the NYSE under the ticker KNRX on September 29, 2025. The ceremony will be held at 11 Wall Street, New York City, and can be viewed live via the NYSE webcast at https://tv.nyse.com/2025-nyse-closing-bells.
KNOREX (NYSE American: KNRX) on December 18, 2025 announced a white-label solution using its flagship platform XPOSM to power a fast-growing live commerce platform. The offering embeds AI-driven programmatic advertising, real-time automation, and audience intelligence into live video environments to convert viewership into measurable conversions across social and streaming channels.
The collaboration aims to enable personalized, multi-channel campaigns, scale across enterprise and emerging partners, and extend KNOREX's market reach by integrating its data-driven automation into third-party digital retail ecosystems.
KNOREX (NYSE American: KNRX) reported that its AI-driven cross-channel marketing platform KNOREX XPO was deployed by one of Canada’s largest dental networks across 450+ clinics, producing measurable operational and commercial gains in Q1 2025.
Key disclosed outcomes: 7% increase in new patient acquisition, 10% revenue growth, and 20% reduction in overall marketing costs. The company attributes results to unified tracking, consolidated paid-media execution, and continuous optimization by its KAIROS AI engine.
KNOREX (NYSE American: KNRX) announced a strategic partnership on October 15, 2025 to integrate a premier, human-verified B2B dataset into its AI-powered XPO advertising platform. The collaboration combines KNOREX’s cross-channel AI and automation with a proprietary B2B database to enable more precise, personalized campaigns at scale.
The integration gives KNOREX customers access to high-quality, human-verified B2B data aimed at accelerating customer acquisition and revenue expansion across technology, financial services, and healthcare. KNOREX says the alignment will deliver deeper insights, smarter targeting, and measurable marketing impact.
KNOREX (NYSE American: KNRX) provided a CEO letter dated October 9, 2025 highlighting its successful listing on the NYSE American and strategic outlook. The company reported 2024 revenue of $10.8M, up 24.0% YoY from $8.7M in 2023, and gross profit of $4.5M, a 40.0% increase year-over-year. Management emphasized investments in its proprietary AI-driven KNOREX XPO platform, geographic expansion in North America and Asia, and use of IPO capital to accelerate growth. The letter frames the listing as a source of market visibility and capital to scale cross-channel programmatic advertising, improve automation and predictive budgeting, and pursue long-term profitable growth.
Knorex (NYSE American: KNRX), an AI-driven digital advertising solutions provider, has successfully completed its Initial Public Offering (IPO) of 3,000,000 Class A ordinary shares at $4.00 per share, raising gross proceeds of $12.0 million before deductions.
The company began trading on the NYSE American on September 29, 2025, under the symbol "KNRX". The underwriters, led by R. F. Lafferty & Co. Inc., have a 45-day option to purchase up to 450,000 additional shares to cover over-allotments. The IPO was conducted on a firm commitment basis with Craft Capital Management LLC serving as co-manager.
FAQ
What is the current stock price of KNOREX LTD. (KNRX)?
What is the market cap of KNOREX LTD. (KNRX)?
